| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Verona Pharma plc | General Counsel | Ordinary Shares | 1,623,487 | $3,207,199 | $1.98 | 01 Feb 2024 | Direct |
| Verona Pharma plc | General Counsel | Ordinary Shares | 1,176,920 | $2,325,005 | $1.98 | 01 Feb 2024 | By Trust |
| Verona Pharma plc | General Counsel | Restricted Share Units | 0 | 01 May 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| VRNA | Verona Pharma plc | 01 Feb 2024 | 3 | -$237,197 | 4 | General Counsel | 05 Feb 2024, 18:10 |
| VRNA | Verona Pharma plc | 01 Nov 2023 | 3 | -$303,254 | 4 | General Counsel | 03 Nov 2023, 20:09 |
| VRNA | Verona Pharma plc | 20 Oct 2023 | 1 | $0 | 4 | General Counsel | 24 Oct 2023, 16:06 |
| VRNA | Verona Pharma plc | 03 Aug 2023 | 5 | -$121,914 | 4 | General Counsel | 07 Aug 2023, 21:15 |
| VRNA | Verona Pharma plc | 01 Aug 2023 | 2 | -$83,415 | 4 | General Counsel | 03 Aug 2023, 20:30 |
| VRNA | Verona Pharma plc | 01 May 2023 | 2 | $0 | 4/A | General Counsel | 11 May 2023, 16:16 |
| VRNA | Verona Pharma plc | 20 Jan 2023 | 7 | -$394,273 | 4 | General Counsel | 03 Feb 2023, 17:15 |
| VRNA | Verona Pharma plc | 26 Sep 2022 | 1 | $0 | 4 | General Counsel | 28 Sep 2022, 16:06 |
| VRNA | Verona Pharma plc | 01 Aug 2022 | 1 | -$53,730 | 4 | General Counsel | 03 Aug 2022, 16:10 |
| VRNA | Verona Pharma plc | 01 May 2022 | 1 | -$41,746 | 4 | General Counsel | 03 May 2022, 20:19 |
| VRNA | Verona Pharma plc | 01 Feb 2022 | 1 | -$62,023 | 4 | General Counsel | 03 Feb 2022, 16:55 |
| VRNA | Verona Pharma plc | 21 Nov 2021 | 11 | -$646,032 | 4 | General Counsel | 27 Dec 2022, 17:50 |
| VRNA | Verona Pharma plc | 01 Nov 2021 | 1 | -$51,133 | 4 | General Counsel | 03 Nov 2021, 19:51 |
| VRNA | Verona Pharma plc | 01 Aug 2021 | 3 | -$250,886 | 4 | General Counsel | 03 Aug 2021, 21:59 |